Views & Analysis Rethinking drug discovery George Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change.
Partner Content Partner Content Less than 3 weeks to SMi's 3rd Annual Drug Discovery Chemist... 3 weeks to SMi's 3rd Annual Drug Discovery Chemistry
Partner Content Partner Content Drug Discovery Chemistry - Speaker Interviews with GSK &... Exclusive Speaker Interviews Released with GSK & Roche
Events Partner Content SMi's 3rd Annual Drug Discovery Chemistry Conference SMi's 3rd Annual Drug Discovery Chemistry
Partner Content Partner Content SMi’s Drug Discovery Chemistry announces key industry speake... SMi’s Drug Discovery Chemistry brochure available
R&D Boosting clinical trial productivity to prove Eroom wrong According to Eroom’s law, drug discovery becomes slower and costlier over time. And the data are, at least in part, bearing that out.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
